z-logo
open-access-imgOpen Access
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
Author(s) -
Siddhartha Jaiswal,
Pradeep Natarajan,
Alexander J. Silver,
Christopher J. Gibson,
Alexander G. Bick,
Eugenia Shvartz,
Marie McConkey,
Namrata Gupta,
Stacey Gabriel,
Diego Ardissino,
Usman Baber,
Roxana Mehran,
Valentı́n Fuster,
John Danesh,
Philippe Frossard,
Danish Saleheen,
Olle Melander,
Galina K. Sukhova,
Doneuberg,
Peter Libby,
Sekar Kathiresan,
Benjamin L. Ebert
Publication year - 2017
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1701719
Subject(s) - medicine , myocardial infarction , coronary artery disease , bone marrow , cardiology , disease , oncology
Clonal hematopoiesis of indeterminate potential (CHIP), which is defined as the presence of an expanded somatic blood-cell clone in persons without other hematologic abnormalities, is common among older persons and is associated with an increased risk of hematologic cancer. We previously found preliminary evidence for an association between CHIP and atherosclerotic cardiovascular disease, but the nature of this association was unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom